Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 6/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.53 |
| ▸ | AKT1 | P31749 | 13/20 | 0.52 |
| ▸ | AKT2 | P31751 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14983597 | 0.95 | AOC3 (0.51) | AOC3KCNH2AKT1AKT2 | |
| SCHEMBL14977193 | 0.91 | AKT1 (0.52) | AKT1AKT2 | |
| SCHEMBL14977051 | 0.86 | AKT1 (0.50) | AOC3AKT1AKT2 | |
| SCHEMBL14983719 | 0.81 | AKT1 (0.47) | AKT1AKT2 | |
| SCHEMBL14975838 | 0.79 | AKT1 (0.49) | AKT1AKT2 | |
| SCHEMBL14976425 | 0.78 | AKT1 (0.52) | AKT1AKT2 | |
| SCHEMBL7119872 | 0.77 | AOC3 (0.74) | AOC3KCNH2 | |
| SCHEMBL14975798 | 0.77 | AKT1 (0.48) | AKT1AKT2 | |
| SCHEMBL14983587 | 0.77 | AKT1 (0.52) | AKT1AKT2 | |
| SCHEMBL14977074 | 0.77 | AKT1 (0.46) | AOC3KCNH2AKT1AKT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013078254-A1 | BICYCLIC HETEROARYL DERIVATIVES AS KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2013-05-30 | — | — | WO | claimed |
| WO-2013078254-A1 | BICYCLIC HETEROARYL DERIVATIVES AS KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2013078254-A1 | BICYCLIC HETEROARYL DERIVATIVES AS KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2013-05-30 | — | — | WO | disclosed |